title: Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
authors.affiliation: Brooke Army Medical Center, Fort Sam Houston, TX.
authors.forename: T D
authors.initials: TD
authors.lastname: Brown
authors.forename: T R
authors.initials: TR
authors.lastname: Fleming
authors.forename: R A
authors.initials: RA
authors.lastname: Shildt
authors.forename: J D
authors.initials: JD
authors.lastname: Cowan
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003953:Diagnosis-Related Groups; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D000873:Anthracenes; C031404:bisantrene